The lowering of the colorectal cancer screening age and the acceleration of the outpatient migration leaves gastroenterology ASCs and endoscopy centers primed for growth.
GI & Endoscopy
Oral microbiome therapy SER-109 could be helpful in fighting recurrent Clostridioides difficile, which causes diarrhea and colitis, according to a study published Jan. 20 in The New England Journal of Medicine.
Acquisition of gastroenterology practices by management service organizations accelerated in 2021, with powerhouses like Miami-based Gastro Health and Southlake, Texas-based GI Alliance expanding their reach nationwide.
Seven gastroenterology practice expansions and new center openings Becker's has covered in the last 30 days:
Four recent gastroenterology research developments from the past 10 days:
Advertisement
Gastroenterologists who engage in buy and bill are more likely to perform ancillary services than those who do not.
Rajiv Sharma, MD, owner of Terre Haute, Ind.-based Digestive Health Associates and nutritional supplement company Dr. Gut Happiness, joined "Becker's ASC Review Podcast" to talk about the importance of branding and technology for practice owners.
Researchers at the Mayo Clinic Cancer Center have found that the drug adagrasib could be helpful in the treatment of gastrointestinal cancers, according to a Feb. 7 Mayo Clinic News Network article.
The FDA has granted 510(k) regulatory clearance to Ambu's aScope, a single-use gastroscope, and aBox 2, a display unit, the company said Feb. 4.
Clinical stage medical diagnostics company Check-Cap received approval from the FDA for its amended Investigational Device Exemption application for C-Scan, allowing for a U.S. pivotal study.